Spire Wealth Management Sells 13,624 Shares of Waters Co. (NYSE:WAT)

Spire Wealth Management decreased its position in shares of Waters Co. (NYSE:WATFree Report) by 96.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 547 shares of the medical instruments supplier’s stock after selling 13,624 shares during the period. Spire Wealth Management’s holdings in Waters were worth $171,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. London Co. of Virginia bought a new position in shares of Waters in the third quarter worth about $158,723,000. Nordea Investment Management AB grew its holdings in shares of Waters by 129.9% in the fourth quarter. Nordea Investment Management AB now owns 973,537 shares of the medical instruments supplier’s stock worth $322,017,000 after purchasing an additional 550,112 shares during the last quarter. Findlay Park Partners LLP bought a new position in shares of Waters in the third quarter worth about $78,017,000. American Century Companies Inc. grew its holdings in shares of Waters by 34.3% in the third quarter. American Century Companies Inc. now owns 832,895 shares of the medical instruments supplier’s stock worth $228,388,000 after purchasing an additional 212,754 shares during the last quarter. Finally, Artisan Partners Limited Partnership bought a new position in shares of Waters in the third quarter worth about $50,369,000. Institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Stifel Nicolaus upped their price target on shares of Waters from $330.00 to $332.00 and gave the stock a “hold” rating in a report on Wednesday. Robert W. Baird lowered their price objective on shares of Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a research note on Wednesday. Barclays lowered their price objective on shares of Waters from $300.00 to $295.00 and set an “underweight” rating for the company in a research note on Wednesday. TD Cowen upped their price objective on shares of Waters from $350.00 to $358.00 and gave the stock a “hold” rating in a research note on Wednesday. Finally, Evercore ISI upped their price objective on shares of Waters from $320.00 to $340.00 and gave the stock an “in-line” rating in a research note on Thursday, April 4th. One research analyst has rated the stock with a sell rating and ten have assigned a hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $305.78.

Check Out Our Latest Research Report on WAT

Insider Buying and Selling

In related news, Director Linda Baddour sold 500 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total value of $177,770.00. Following the transaction, the director now owns 2,250 shares in the company, valued at approximately $799,965. The sale was disclosed in a filing with the SEC, which is available through this link. 0.82% of the stock is owned by corporate insiders.

Waters Stock Performance

Shares of Waters stock opened at $351.11 on Friday. The firm has a market capitalization of $20.83 billion, a P/E ratio of 34.46, a PEG ratio of 6.99 and a beta of 0.98. The company has a quick ratio of 1.57, a current ratio of 1.94 and a debt-to-equity ratio of 1.60. The company has a 50 day moving average price of $333.03 and a 200 day moving average price of $312.13. Waters Co. has a 52 week low of $231.90 and a 52 week high of $363.80.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, beating the consensus estimate of $2.10 by $0.11. Waters had a net margin of 20.75% and a return on equity of 66.59%. The firm had revenue of $636.80 million during the quarter, compared to analyst estimates of $635.57 million. During the same period last year, the firm posted $2.49 EPS. Waters’s revenue was down 7.0% on a year-over-year basis. Sell-side analysts expect that Waters Co. will post 11.86 EPS for the current year.

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.